Telmisartan Market : Full in-Depth Analysis by Top Key Players Medtronic Plc., General Electric Company, C. R. Bard, Inc., ConvaTec Group Plc. Smith Medical, Inc
Availability of better treatment options for hypertension has lead substantial portion of the hypertensive population with controlled blood pressure. But rising population with cardiovascular, and associated disorders urges need for different antihypertensive drugs in the global market. Telmisartan is a non-peptide angiotensin receptor blocker intended for treatment of hypertension and other cardiovascular disorders. Telmisartan was approved by the US Food and Drug Administration (USFDA) in 1998, for the treatment of hypertension alone or in combination with other compounds.
View full press release